“…Several studies have reported that disease groups, such as cancer, bacterial, and viral infections, and cardiovascular diseases had increased levels of TF-like antigen measured by Imubind [ [47] , [48] , [49] , [50] , [51] , [52] , [53] , [54] , [55] , [56] , [57] ] or Quantikine [ 46 , 58 , 59 ] compared with healthy controls ( Table ). These studies report statistically significant increases in TF-like antigen in different disease groups using the Imubind and Quantikine ELISAs.…”